CompletedNot Applicable

EDOF and Multifocal IOL Study

Austria50 participantsStarted 2020-11-09

Plain-language summary

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

Who can participate

Age range50 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Bilateral age-related cataract for which phacoemulsification extraction and posterior IOL implantation has planned * Age 50-90 * Visual potential in both eyes of 20/30 or better as determined by investigators estimation * Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant Exclusion Criteria: * Preceding ocular surgery or trauma * Relevant other ophthalmic diseases (such as retinal degenerations, etc.) * Uncontrolled systemic or ocular disease

What they're measuring

distant corrected near visual acuity

Timeframe: 6 months

Trial details

NCT IDNCT05573529

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-23

View on ClinicalTrials.gov More Age-related Cataract trials